Corvus Pharmaceuticals, Inc. - CRVS

SEC FilingsOur CRVS Tweets

About Gravity Analytica

Recent News

  • 05.20.2026 - Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference
  • 05.07.2026 - Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results

Recent Filings

  • 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 05.15.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
  • 05.14.2026 - EX-99.1 EX-99.1
  • 05.14.2026 - 8-K Current report
  • 05.07.2026 - 8-K Current report
  • 05.07.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 05.07.2026 - EX-99.1 EX-99.1
  • 05.07.2026 - S-8 Securities to be offered to employees in employee benefit plans
  • 04.27.2026 - 4 Statement of changes in beneficial ownership of securities
  • 04.27.2026 - 3 Initial statement of beneficial ownership of securities